Market closed
Stryker/$SYK
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Stryker
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.
Ticker
$SYK
Sector
Health Care
Trading on
NYSE
Industry
Health Care Equipment & Supplies
Headquarters
Portage, United States
Employees
52,000
Website
Stryker Metrics
BasicAdvanced
$141B
41.21
$8.97
0.90
$3.15
0.87%
Price and volume
Market cap
$141B
Beta
0.9
52-week high
$370.01
52-week low
$314.93
Average daily volume
1M
Dividend rate
$3.15
Financial strength
Current ratio
1.681
Quick ratio
0.806
Long term debt to equity
51.245
Total debt to equity
64.487
Dividend payout ratio (TTM)
34.19%
Interest coverage (TTM)
12.50%
Management effectiveness
Return on assets (TTM)
7.27%
Return on equity (TTM)
18.58%
Valuation
Price to earnings (TTM)
41.206
Price to revenue (TTM)
6.57
Price to book
7.12
Price to tangible book (TTM)
-15,644.74
Price to free cash flow (TTM)
50.134
Dividend yield (TTM)
0.85%
Forward dividend yield
0.87%
Growth
Revenue change (TTM)
9.94%
Earnings per share change (TTM)
26.66%
3-year revenue growth (CAGR)
9.60%
3-year earnings per share growth (CAGR)
18.01%
3-year dividend per share growth (CAGR)
8.52%
What the Analysts think about Stryker
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Stryker stock.
Stryker Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Stryker Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Stryker News
AllArticlesVideos
Viscogliosi Brothers Completes Acquisition of U.S. Spine Business from Stryker, Creating VB Spine, LLC
GlobeNewsWire·3 weeks ago
Stryker completes sale of U.S. spinal implants business
GlobeNewsWire·3 weeks ago
Stryker announces intention to nominate Manny Maceda to board of directors
GlobeNewsWire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Market closed
Upcoming events
Apr30
Stryker
Dividend·Payment
$0.84
Per share
FAQs
What’s the current market cap for Stryker stock?
Stryker (SYK) has a market cap of $141B as of April 24, 2025.
What is the P/E ratio for Stryker stock?
The price to earnings (P/E) ratio for Stryker (SYK) stock is 41.21 as of April 24, 2025.
Does Stryker stock pay dividends?
Yes, the Stryker (SYK) stock pays dividends to shareholders. As of April 24, 2025, the dividend rate is $3.15 and the yield is 0.87%. Stryker has a payout ratio of 34.19% on a trailing twelve-month basis.
When is the next Stryker dividend payment date?
The next Stryker (SYK) dividend payment is scheduled for April 30, 2025.
What is the beta indicator for Stryker?
Stryker (SYK) has a beta rating of 0.9. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.